select a format

Single User License
USD 2500 INR 161975
Site License
USD 5000 INR 323950
Corporate User License
USD 7500 INR 485925

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Bone Metastasis Global Clinical Trials Review, H1, 2015

Bone Metastasis Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2565CTIDB
  • |
  • Pages: 179
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Bone Metastasis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Bone Metastasis Global Clinical Trials Review, H1, 2015" provides data on the Bone Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Metastasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Metastasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Bone Metastasis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Bone Metastasis to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Bone Metastasis to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Bone Metastasis 25

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Bone Metastasis Therapeutics Clinical Trials 33

Prominent Drugs 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

Novartis AG 35

Clinical Trial Overview of Novartis AG 35

Amgen Inc. 41

Clinical Trial Overview of Amgen Inc. 41

F. Hoffmann-La Roche Ltd. 43

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 43

Bayer AG 45

Clinical Trial Overview of Bayer AG 45

AstraZeneca PLC 47

Clinical Trial Overview of AstraZeneca PLC 47

Merck & Co., Inc. 48

Clinical Trial Overview of Merck & Co., Inc. 48

Pfizer Inc. 49

Clinical Trial Overview of Pfizer Inc. 49

AbbVie Inc. 50

Clinical Trial Overview of AbbVie Inc. 50

Galil Medical Ltd. 51

Clinical Trial Overview of Galil Medical Ltd. 51

Exelixis, Inc. 52

Clinical Trial Overview of Exelixis, Inc. 52

Clinical Trial Overview of Top Institutes / Government 53

University of Texas M. D. Anderson Cancer Center 53

Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 53

University Health Network 54

Clinical Trial Overview of University Health Network 54

National Cancer Institute 55

Clinical Trial Overview of National Cancer Institute 55

SWOG 56

Clinical Trial Overview of SWOG 56

West China Hospital 57

Clinical Trial Overview of West China Hospital 57

Washington University School of Medicine 58

Clinical Trial Overview of Washington University School of Medicine 58

Massachusetts General Hospital 59

Clinical Trial Overview of Massachusetts General Hospital 59

Radiation Therapy Oncology Group 60

Clinical Trial Overview of Radiation Therapy Oncology Group 60

Sun Yat-sen University 61

Clinical Trial Overview of Sun Yat-sen University 61

Memorial Sloan Kettering Cancer Center 62

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 62

Five Key Clinical Profiles 63

Appendix 177

Abbreviations 177

Definitions 177

Research Methodology 178

Secondary Research 178

About GlobalData 179

Contact Us 179

Disclaimer 179

Source 179

List of Figures

Bone Metastasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Bone Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Bone Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Bone Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Bone Metastasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Bone Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Bone Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Bone Metastasis to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Bone Metastasis to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Bone Metastasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Bone Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Bone Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Bone Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Bone Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31

Bone Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Bone Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Bone Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

GlobalData Methodology 178

List of Tables

Bone Metastasis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Bone Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Bone Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Bone Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Bone Metastasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Bone Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Bone Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Bone Metastasis to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Bone Metastasis to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Bone Metastasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Bone Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Bone Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Bone Metastasis Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Bone Metastasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Bone Metastasis Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Bone Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Bone Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31

Bone Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Bone Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Bone Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 35

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 41

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 43

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 45

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 47

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 48

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 49

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 50

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galil Medical Ltd., 2015* 51

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2015* 52

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 53

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 54

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 55

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015* 56

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2015* 57

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2015* 58

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 59

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2015* 60

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 61

Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 62

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Bone Metastasis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Bone Metastasis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com